We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+16.26%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.58B
AUM Growth
+$476M
Cap. Flow
-$79.2M
Cap. Flow %
-1.73%
Top 10 Hldgs %
7.86%
Holding
734
New
63
Increased
245
Reduced
365
Closed
52

Sector Composition

Rank Sector Weight
1 Industrials 20.81%
2 Financials 20.14%
3 Technology 12.67%
4 Healthcare 11.12%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCSL icon
451
Oaktree Specialty Lending
OCSL
$1.12B
$2.31M 0.05%
113,266
-1,795
-2% -$35.4K
BVH
452
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$2.31M 0.05%
30,781
-540
-2% -$31.5K
GWRS icon
453
Global Water Resources
GWRS
$217M
$2.3M 0.05%
175,994
-277
-0.2% -$3.12K
ATO icon
454
Atmos Energy
ATO
$28.5B
$2.29M 0.05%
19,736
-1,174
-6% -$131K
VBNK
455
VersaBank
VBNK
$619M
$2.28M 0.05%
207,930
-234
-0.1% -$1.92K
MTCH icon
456
Match Group
MTCH
$8.45B
$2.27M 0.05%
62,055
-4,435
-7% -$150K
WS icon
457
Worthington Steel
WS
$1.95B
$2.25M 0.05%
+80,154
New +$2.2M
INTT icon
458
inTEST
INTT
$166M
$2.24M 0.05%
164,749
+39,741
+32% +$527K
ESE icon
459
ESCO Technologies
ESE
$7.77B
$2.23M 0.05%
19,034
+1,898
+11% +$200K
CDMO
460
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$2.22M 0.05%
341,888
-16,856
-5% -$109K
DCOM icon
461
Dime Commercial Bancshares
DCOM
$1.79B
$2.22M 0.05%
82,316
+2,175
+3% +$46.6K
ICLR icon
462
Icon
ICLR
$12.7B
$2.21M 0.05%
7,796
+933
+14% +$241K
SPTN
463
DELISTED
SpartanNash
SPTN
$2.19M 0.05%
95,290
-1,534
-2% -$34.9K
MLTX icon
464
MoonLake Immunotherapeutics
MLTX
$1.39B
$2.13M 0.05%
+35,335
New +$1.82M
PINC
465
DELISTED
Premier
PINC
$2.13M 0.05%
95,356
-96,000
-50% -$1.98M
SKYT
466
DELISTED
SkyWater Technology
SKYT
$2.13M 0.05%
221,294
-3,778
-2% -$25.3K
TPR icon
467
Tapestry
TPR
$32.4B
$2.12M 0.05%
57,631
-48,042
-45% -$1.48M
JLL icon
468
Jones Lang LaSalle
JLL
$16.7B
$2.1M 0.05%
11,100
+1,107
+11% +$167K
INVE icon
469
Identive
INVE
$62.9M
$2.08M 0.05%
252,764
-3,761
-1% -$26.5K
BDTX icon
470
Black Diamond Therapeutics
BDTX
$118M
$2.08M 0.05%
740,901
-9,391
-1% -$22K
ALGT icon
471
Allegiant Air
ALGT
$2.42B
$2.07M 0.05%
25,023
+9,712
+63% +$701K
XPOF icon
472
Xponential Fitness
XPOF
$205M
$2.05M 0.04%
158,837
+93,940
+145% +$1.27M
AXGN icon
473
Axogen
AXGN
$2.6B
$2.04M 0.04%
299,202
-5,055
-2% -$28.1K
WINA icon
474
Winmark
WINA
$1.37B
$2.04M 0.04%
4,892
-82
-2% -$34.5K
SHCR
475
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$2.04M 0.04%
1,884,925
-27,975
-1% -$28.7K

Similar funds

Kennedy Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Kennedy Capital Management held 734 positions worth $4.58B, up 12% from $4.1B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Kennedy Capital Management's Q4 2023 filing shows 63 new, 245 increased, 365 reduced and 52 closed positions. Its largest new stake was Silicon Motion: 128,520 shares worth $7.87M. The largest sale was NextGen Healthcare, Inc. Common Stock, an estimated $18.7M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

  • Kennedy Capital Management's largest Q4 2023 buy was Silicon Motion: 128,520 shares worth $7.87M.
  • Kennedy Capital Management added most to Barnes Group Inc. in Q4 2023, an estimated $17.5M increase.
  • Kennedy Capital Management's biggest Q4 2023 reduction was Perficient Inc, cutting an estimated $10.6M.
  • Kennedy Capital Management fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $18.7M.
  • Kennedy Capital Management's ten largest holdings make up 7.9% of its $4.58B portfolio in Q4 2023.
  • Kennedy Capital Management opened 63 new positions and closed 52 in Q4 2023.
  • Kennedy Capital Management's portfolio value rose 12% quarter-over-quarter to $4.58B.

Based on Kennedy Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.